Clinical trial data platform
ClinicalTrials.gov (global)
594,309
Studies (totalCount)
Ongoing trials by phase
1,850
Early Phase 1 (preclinical)
11,125
Phase 1
18,768
Phase 2
7,990
Phase 3
Completed trials
324,591
Completed (overall status)
Last synced: 2026-07-17 15:49:12 (UTC server time).
Recently FDA-approved drugs
OMCAZIO
- Ingredient
- CABOZANTINIB LAURYLSULFATE
- Approval
- 2026-09-03
- Application
- NDA220613
- Sponsor
- HANDA ONCOL
NAVITRUX
- Ingredient
- FOSAPREPITANT
- Approval
- 2026-06-24
- Application
- NDA220436
- Sponsor
- AVYXA HOLDINGS
XOCOVA
- Ingredient
- ENSITRELVIR
- Approval
- 2026-05-29
- Application
- NDA220442
- Sponsor
- SHIONOGI
EPINEPHRINE
- Ingredient
- EPINEPHRINE
- Approval
- 2026-03-30
- Application
- NDA220626
- Sponsor
- BAXTER HLTHCARE CORP
YUVIWEL
- Ingredient
- NAVEPEGRITIDE
- Approval
- 2026-02-27
- Application
- NDA219164
- Sponsor
- ASCENDIS
LOARGYS
- Ingredient
- PEGZILARGINASE-NBLN
- Approval
- 2026-02-23
- Application
- BLA761211
- Sponsor
- IMMEDICA PHARMA AB
Recently completed Phase 3 trials
Tranexamic Acid for Reduction of Transfusion in Abdominal Surgery
- Topic
- Surgical Blood Loss
- Start
- 2024-06-17
- Completion
- 2026-10-01
- Sponsor
- Ulrich Ronellenfitsch, MD
Thrombolysis With Recombinant Non-immunogenic Staphylokinase vs Surgery in Patients With Acute Limb Ischemia FORAT Trial
- Topic
- Acute Limb Ischemia
- Start
- 2022-12-26
- Completion
- 2026-09-30
- Sponsor
- Supergene, LLC
Sildinafil in Pulmonary Hypertension-Rheumatic Chronic Valvular Disease(RCT)
- Topic
- Pulmonary Hypertension
- Start
- 2025-08-01
- Completion
- 2026-09-23
- Sponsor
- Sindh Institute of Cardiovascular Diseases
Reducing Breathlessness With Dronabinol in COPD Patients
- Topic
- COPD
- Start
- 2025-02-26
- Completion
- 2026-09-21
- Sponsor
- Vejle Hospital
Dapagliflozin Versus Dexamethasone Role in Pre-operative Management of Non- Diabetic Brain Tumor Patients
- Topic
- Glioma
- Start
- 2025-01-20
- Completion
- 2026-09-20
- Sponsor
- Tanta University
Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX
- Topic
- Hemophilia
- Start
- 2019-01-09
- Completion
- 2026-09-14
- Sponsor
- Genzyme, a Sanofi Company
ClinicalTrials.gov search results
- NCT07721467RECRUITINGINTERVENTIONALPHASE2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin - NCT07187336COMPLETEDINTERVENTIONALNA
The Efficacy and Safety of Shoulder Motion Style Acupuncture Treatment (MSAT) on in Patients With Shoulder Pain Caused by Traffic Accidents - NCT06686212COMPLETEDINTERVENTIONALNA
Comparative Effects of Sensory Re-education and Neural Mobilization in CTS Patients - NCT04168008COMPLETEDINTERVENTIONALNA
A Peer-Led Intervention to Improve Postpartum Retention in HIV Care - NCT07664358RECRUITINGOBSERVATIONAL
Fibrinogen-to-Albumin Ratio as a Predictor of Acute Respiratory Distress Syndrome in Traumatic Brain Injury - NCT07867197RECRUITINGINTERVENTIONALNA
Effectiveness of Digital Cardiac Rehabilitation on Functional Capacity in Patients With Myocardial Infarction - NCT07868224NOT_YET_RECRUITINGINTERVENTIONALNA
Validating Blinding Maintenance of a Sham-Sensitization Control Design for Sensitization Acupuncture Trials - NCT06420323ACTIVE_NOT_RECRUITINGOBSERVATIONAL
NovoX®Cup as Primary Dressing After Breast Reduction - NCT05708053COMPLETEDINTERVENTIONALPHASE3
Cardio-protective Effect of Metformin in Patients Undergoing PCI - NCT07850622COMPLETEDINTERVENTIONALNA
High-Intensity Interval Training and Progressive Muscle Relaxation as a Movement-Based Group Intervention for the Non-Pharmacological Prevention of Adolescent Migraine - NCT06052631NOT_YET_RECRUITINGOBSERVATIONAL
Microneurographic Assessment of Peripheral Nerves in Healthy Volunteers and Individuals With Sensory Dysfunction Caused by Inherited Mutations in the PIEZO2 Gene - NCT07388524RECRUITINGINTERVENTIONALPHASE3
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial - NCT07333261ACTIVE_NOT_RECRUITINGINTERVENTIONALPHASE1
Study of BMS-986453 in Newly Diagnosed Multiple Myeloma - NCT06694454SUSPENDEDINTERVENTIONALPHASE1, PHASE2
Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC) - NCT07554339RECRUITINGINTERVENTIONALPHASE3
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015) - NCT07388537NOT_YET_RECRUITINGOBSERVATIONAL
Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and Adults - NCT07261631RECRUITINGINTERVENTIONALPHASE1
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors - NCT07867431RECRUITINGINTERVENTIONALNA
Effects of Incentive Spirometry Versus Diaphragmatic Breathing on Oxygen Saturation and Heart-rate Variability in Post Percutaneous Coronary Intervention Patients - NCT03934372RECRUITINGINTERVENTIONALPHASE1, PHASE2
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors - NCT07664995NOT_YET_RECRUITINGINTERVENTIONALNA
Determining the Effects of Ischemic Conditioning and Neuromuscular Electrical Stimulation on Overall Function After Lower Limb Amputation
MediTrans services
Request data-backed reports, medical writing, or custom clinical intelligence deliverables.
